Scripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2024

Overview

Scripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2024 is an on-demand educational program originally held as a live conference on May 18, 2024, organized by Scripps Conference Services & CME. This comprehensive course addresses critical aspects of atherosclerotic cardiovascular disease (ASCVD), focusing on prevention, diagnosis, treatment, and ongoing management to support clinicians in improving patient outcomes. The content covers advanced clinical strategies, including personalized medicine, genomics, and novel therapeutic approaches in cardiovascular care.

On-demand cardiology education — accessible anytime, anywhere.

Format: 15 videos + 1 PDF
Total size: 3.63 GB

Agenda

This program presents detailed sessions covering a wide range of topics related to cardiovascular atherosclerosis, integrating evidence-based guidelines and emerging therapies.

• AI in Preventive Cardiology — Sanjeev Bhavnani, MD
• Chronic Kidney Disease and Advanced Hypertension Management — Christian Mende, MD
• Hypertension Management: Know the Guidelines and Be Ready for Future Therapies — David Cork, MD
• Master Class on LDL-C, LP(a), non-HDL: How Low to Go — Douglas Triffon, MD
• Obesity: A Serious Cardiovascular Risk Factor; A Review of GLP1 Agonist Therapies — Lauren Vincent, MD
• Optimal Diet, Lifestyle, and Supplements to Promote Longevity — Carol Kirkpatrick, PhD
• Panel Discussion Q&A Sessions 1-4
• Peri-Operative Management of High-Risk Patients with Pulmonary Hypertension and Heart Failure — J. Thomas Heywood, MD
• The Role of Integrative Medicine in Cardiology — Christopher Suhar, MD
• Treating Inflammation to Reduce Atherosclerotic Risk — Michael Garshick, MD
• Triglycerides and Low HDL: Best Practices to Optimize Outcomes — P. Barton Duell, MD
• Women’s Hormonal Health: Risks and Benefits of Supplementing — Sarah Dalhoumi, MD

Educational Objectives

• Discuss principles and applications of personalized medicine and genomics in ASCVD management.
• Describe advances in hypertension management and its impact on cardiovascular disease.
• Assess glucagon-like peptide-1 (GLP-1) agonists in pharmacotherapy of obesity and type 2 diabetes.
• Evaluate high-sensitivity troponin for risk assessment combined with clinical and laboratory data.
• Explain health care provider roles in genetic testing for familial hypercholesterolemia.
• Apply current guidelines for diagnosing and treating dyslipidemia, including lipid-lowering therapy.
• Assess impact of new lipid-lowering agents on patient outcomes.
• Review guidelines and evidence-based recommendations for heart failure therapy selection.
• Determine potential roles of supplements in primary and secondary ASCVD prevention.
• Describe non-invasive coronary evaluation methods, including CT coronary artery imaging.
• Summarize current knowledge on nonalcoholic fatty liver disease and its contribution to cardiovascular disease.
• Analyze cardiovascular effects and risks of testosterone therapy in men.

Speakers

• Sanjeev Bhavnani, MD
• Christian Mende, MD
• David Cork, MD
• Douglas Triffon, MD
• Lauren Vincent, MD
• Carol Kirkpatrick, PhD
• J. Thomas Heywood, MD
• Christopher Suhar, MD
• Michael Garshick, MD
• P. Barton Duell, MD
• Sarah Dalhoumi, MD

Target Audience

This course is designed for physician assistants, cardiologists, and fellows seeking to enhance their clinical knowledge and management strategies related to cardiovascular atherosclerosis and associated risk factors.

Why This Topic Matters

Scripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2024 addresses the ongoing clinical challenge of effectively managing atherosclerotic cardiovascular disease, which remains a leading cause of morbidity and mortality globally. Focused cardiology education on this topic supports healthcare professionals in applying up-to-date preventative and therapeutic approaches in their practice.

By providing access through MedHub Central, this program facilitates continuous professional development and reinforces clinical expertise in cardiovascular disease management, promoting improved patient care within the specialty of cardiology.